Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Sophie Fosså

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Geographic Areas

Norway

Procedures

Living Beings

Survivors

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Questionnaires

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
51
Dahl, Alv
44
Aass, Nina
38
Stenwig, Anna
28
Berner, Aasmund
25
Nesland, Jahn
22
Paus, Elisabeth
18
Kaalhus, Olav
17
Lothe, Ragnhild
15
Klepp, Olbjørn
14
Lilleby, Wolfgang
13
Heimdal, Ketil
12
Jacobsen, AB
12
Dahl, Olav
12
Wist, Erik
11
Bremnes, Roy

Sign-in to see all Coauthors

Publications

TOP 3
Zaikova O; Giercksky K-E; Fosså S D; Kvaløy S; Johannesen T B; Skjeldal S
A population-based study of spinal metastatic disease in South-East Norway.
Fosså Sophie D; Oldenburg Jan; Dahl Alv A
Short- and long-term morbidity after treatment for testicular cancer.
Oldenburg Jan; Fosså Sophie D
Late relapse of nonseminomatous germ cell tumours.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Sophie Fosså (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zaikova O; Giercksky K-E; Fosså S D; Kvaløy S; Johannesen T B; Skjeldal S
A population-based study of spinal metastatic disease in South-East Norway.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2009;21(10):753-9.
2009: Fosså Sophie D; Oldenburg Jan; Dahl Alv A
Short- and long-term morbidity after treatment for testicular cancer.
BJU international 2009;104(9 Pt B):1418-22.
2009: Oldenburg Jan; Fosså Sophie D
Late relapse of nonseminomatous germ cell tumours.
BJU international 2009;104(9 Pt B):1413-7.
2009: Reinertsen Kristin Valborg; Cvancarova Milada; Wist Erik; Bjøro Trine; Dahl Alv A; Danielsen Turi; Fosså Sophie D
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample.
International journal of radiation oncology, biology, physics 2009;75(3):764-70.
2009: Dybvik Eva; Furnes Ove; Fosså Sophie D; Trovik Clement; Lie Stein Atle
Long-term risk of receiving a total hip replacement in cancer patients.
Cancer epidemiology 2009;33(3-4):235-41.
2009: Nesvold Inger-Lise; Fosså Sophie D; Naume Bjørn; Dahl Alv A
Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors.
Breast cancer research and treatment 2009;117(2):281-8.
2009: Michelsen Trond M; Dørum Anne; Tropé Claes G; Fosså Sophie D; Dahl Alv A
Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(6):1029-36.
2009: Wethal T; Lund M-B; Edvardsen T; Fosså S D; Pripp A H; Holte H; Kjekshus J; Fosså A
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.
British journal of cancer 2009;101(4):575-81.
2009: Oldenburg Jan; Wahlqvist Rolf; Fosså Sophie D
Late relapse of germ cell tumors.
World journal of urology 2009;27(4):493-500.
2009: Orre Ingrid J; Murison Robert; Dahl Alv A; Ueland Thor; Aukrust Pål; Fosså Sophie D
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.
Brain, behavior, and immunity 2009;23(6):868-74.
2009: Haugnes Hege S; Aass Nina; Fosså Sophie D; Dahl Olav; Brydøy Marianne; Aasebø Ulf; Wilsgaard Tom; Bremnes Roy M
Pulmonary function in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2779-86.
2009: Grov Ellen Karine; Fosså Sophie D; Dahl Alv A
Is somatic comorbidity associated with more somatic symptoms, mental distress, or unhealthy lifestyle in elderly cancer survivors?
Journal of cancer survivorship : research and practice 2009;3(2):109-16.
2009: Kvåle Rune; Møller Bjørn; Wahlqvist Rolf; Fosså Sophie D; Berner Aasmund; Busch Christer; Kyrdalen Anne E; Svindland Aud; Viset Trond; Halvorsen Ole J
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
BJU international 2009;103(12):1647-54.
2009: Skaali Tone; Fosså Sophie D; Bremnes Roy; Dahl Olav; Haaland Carl Fredrik; Hauge Erik Rønneberg; Klepp Olbjørn; Oldenburg Jan; Wist Erik; Dahl Alv A
Fear of recurrence in long-term testicular cancer survivors.
Psycho-oncology 2009;18(6):580-8.
2009: Vistad Ingvild; Kristensen Gunnar B; Fosså Sophie D; Dahl Alv A; Mørkrid Lars
Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy.
International journal of radiation oncology, biology, physics 2009;73(4):1141-7.
2009: Fosså Sophie D; Egey Andrea; Haukaas Svein Andreas; Angelsen Anders; Klepp Olbjørn; Berge Viktor; Axcrona Karol; Lilleby Wolfgang
[Incorrect about hormone treatment in prostatic cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2009;129(5):429.
2009: Widmark Anders; Klepp Olbjørn; Solberg Arne; Damber Jan-Erik; Angelsen Anders; Fransson Per; Lund Jo-Asmund; Tasdemir Ilker; Hoyer Morten; Wiklund Fredrik; Fosså Sophie D;
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
Lancet 2009;373(9660):301-8.
2009: Stensheim Hanne; Møller Bjørn; van Dijk Tini; Fosså Sophie D
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):45-51.
2009: Mai Phuong L; Chen Bingshu E; Tucker Kathy; Friedlander Michael; Phillips Kelly-Anne; Hogg David; Jewett Michael A S; Bodrogi Istvan; Geczi Lajos; Olah Edith; Heimdal Ketil; Fosså Sophie D; Nathanson Katherine L; Korde Larissa; Easton Douglas F; Dudakia Darshna; Huddart Robert; Stratton Michael R; Bishop D Timothy; Rapley Elizabeth A; Greene Mark H
Younger age-at-diagnosis for familial malignant testicular germ cell tumor.
Familial cancer 2009;8(4):451-6.
2009: Liavaag Astrid Helene; Dørum Anne; Fosså Sophie D; Tropé Claes; Dahl Alv A
Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors.
BMC cancer 2009;9():2.
2009: Gudbergsson Saevar B; Fosså Sophie D; Lindbohm Marja-Liisa; Dahl Alv A
Received and needed social support at the workplace in Norwegian and Finnish stage 1 breast cancer survivors: a study from the Nordic Study Group of Cancer and Work (NOCWO).
Acta oncologica (Stockholm, Sweden) 2009;48(1):67-75.
2008: Fosså Sophie D; Dahl Alv A; Smeland Sigbjørn; Thorsen Lene; Loge Jon Håvard
[Rehabilitation after cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(22):2615-6.
2008: Fosså Sophie D; Kvaløy Julie; Kvaløy Stein; Loge Jon Håvard; Dahl Alv A
[Courses for cancer patients--15 years' experience at The Montebello Centre in Norway]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(22):2554-7.
2008: van Andel George; Bottomley Andrew; Fosså Sophie D; Efficace Fabio; Coens Corneel; Guerif Stephane; Kynaston Howard; Gontero Paolo; Thalmann George; Akdas Atif; D'Haese Sven; Aaronson Neil K
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
European journal of cancer (Oxford, England : 1990) 2008;44(16):2418-24.
2008: Berg Arne; Bruland Øyvind S; Fosså Sophie D; Nesland Jahn M; Berner Aasmund; Schirmer Cecilie; Lilleby Wolfgang
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
The Prostate 2008;68(15):1607-14.
2008: Oldenburg Jan; Fosså Sophie D; Ikdahl Tone
Genetic variants associated with cisplatin-induced ototoxicity.
Pharmacogenomics 2008;9(10):1521-30.
2008: Haugnes H S; Aass N; Fosså S D; Dahl O; Klepp O; Wist E A; Wilsgaard T; Bremnes R M
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors.
Journal of cancer survivorship : research and practice 2008;2(3):128-37.
2008: Berg Gudbergsson Saevar; Fosså Sophie D; Dahl Alv A
Is cancer survivorship associated with reduced work engagement? A NOCWO Study.
Journal of cancer survivorship : research and practice 2008;2(3):159-68.
2008: Steinsvik Eivind A; Fosså Sophie D; Lilleby Wolfgang; Eilertsen Karsten
Fertility issues in patients with prostate cancer.
BJU international 2008;102(7):793-5.
2008: Thorsen Lene; Courneya Kerry S; Stevinson Clare; Fosså Sophie D
A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(9):987-97.
2008: Hernes Eivor; Johansson Lars A; Fosså Sophie D; Pedersen Anne G; Glattre Eystein
High prostate cancer mortality in Norway evaluated by automated classification of medical entities.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2008;17(4):331-5.
2008: Fosså S D; Loge J H; Dahl A A
Long-term survivorship after cancer: how far have we come?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 5():v25-9.
2008: Fosså Sophie D; Dahl Alv A
Fertility and sexuality in young cancer survivors who have adult-onset malignancies.
Hematology/oncology clinics of North America 2008;22(2):291-303, vii.
2008: Orre Ingrid J; Fosså Sophie D; Murison Robert; Bremnes Roy; Dahl Olav; Klepp Olbjørn; Loge Jon H; Wist Erik; Dahl Alv A
Chronic cancer-related fatigue in long-term survivors of testicular cancer.
Journal of psychosomatic research 2008;64(4):363-71.
2008: Fosså Sophie D; Vassilopoulou-Sellin Rena; Dahl Alv A
Long term physical sequelae after adult-onset cancer.
Journal of cancer survivorship : research and practice 2008;2(1):3-11.
2008: Kiserud Cecilie E; Magelssen Henriette; Fedorcsak Peter; Fosså Sophie D
[Gonadal function after cancer treatment in adult men]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(4):461-5.
2008: Oldenburg Jan; Lehne Gustav; Fosså Sophie D
[Testicular cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(4):457-60.
2008: Liavaag Astrid H; Dørum Anne; Bjøro Trine; Oksefjell Halldis; Fosså Sophie D; Tropé Claes; Dahl Alv A
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach.
Gynecologic oncology 2008;108(2):348-54.
2008: Bjerkehagen Bodil; Smeland Sigbjørn; Walberg Lise; Skjeldal Sigmund; Hall Kirsten Sundby; Nesland Jahn M; Småstuen Milada Cvancarova; Fosså Sophie D; Saeter Gunnar
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital.
Acta oncologica (Stockholm, Sweden) 2008;47(8):1475-82.
2008: Nesvold Inger-Lise; Dahl Alv A; Løkkevik Erik; Marit Mengshoel Anne; Fosså Sophie D
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Acta oncologica (Stockholm, Sweden) 2008;47(5):835-42.
2008: Fosså Sophie D
A randomized phase II trial comparing weekly taxotere plus prednisolone versus prednisolone alone in androgen-independent prostate cancer.
Frontiers of radiation therapy and oncology 2008;41():108-16.
2008: Ikdahl Tone; Josefsen Dag; Jakobsen Erling; Delabie Jan; Fosså Sophie D
Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature.
Acta oncologica (Stockholm, Sweden) 2008;47(3):466-9.
2008: Vågane Randi; Bruland Øyvind S; Fosså Sophie D; Olsen Dag R
Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation.
Acta oncologica (Stockholm, Sweden) 2008;47(2):248-54.
2007: Fosså Sophie D; Jacobsen Anne-Birgitte; Ginman Claes; Jacobsen Inga N; Overn Sissel; Iversen Jon R; Urnes Thomas; Dahl Alv A; Veenstra Marijke; Sandstad Berit
Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.
European urology 2007;52(6):1691-8.
2007: Brown Linda Morris; Chen Bingshu E; Pfeiffer Ruth M; Schairer Catherine; Hall Per; Storm Hans; Pukkala Eero; Langmark Frøydis; Kaijser Magnus; Andersson Michael; Joensuu Heikki; Fosså Sophie D; Travis Lois B
Risk of second non-hematological malignancies among 376,825 breast cancer survivors.
Breast cancer research and treatment 2007;106(3):439-51.
2007: Chaturvedi Anil K; Engels Eric A; Gilbert Ethel S; Chen Bingshu E; Storm Hans; Lynch Charles F; Hall Per; Langmark Froydis; Pukkala Eero; Kaijser Magnus; Andersson Michael; Fosså Sophie D; Joensuu Heikki; Boice John D; Kleinerman Ruth A; Travis Lois B
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Journal of the National Cancer Institute 2007;99(21):1634-43.
2007: Berg Arne; Lilleby Wolfgang; Bruland Oyvind Sverre; Fosså Sophie Dorothea
10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy.
International journal of radiation oncology, biology, physics 2007;69(4):1074-83.
2007: Gudbergsson Saevar B; Fosså Sophie D; Ganz Patricia A; Zebrack Brad J; Dahl Alv A
The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(11):1309-18.
2007: Dahl Alv A; Bremnes Roy; Dahl Olav; Klepp Olbjørn; Wist Erik; Fosså Sophie D
Is the sexual function compromised in long-term testicular cancer survivors?
European urology 2007;52(5):1438-47.
2007: Vistad I; Fosså S D; Kristensen G B; Dahl A A
Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy.
BJOG : an international journal of obstetrics and gynaecology 2007;114(9):1150-8.
2007: Aksnes Liv Hege; Hall Kirsten Sundby; Jebsen Nina; Fosså Sophie D; Dahl Alv A
Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(9):1087-96.
2007: Schlichting Ellen; Nielsen Harriet Bjerrum; Fosså Sophie Dorothea; Aasland Olaf Gjerløw
[Women's academic careers in medicine]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2007;127(16):2109-12.
2007: Schairer Catherine; Hisada Michie; Chen Bingshu E; Brown Linda M; Howard Regan; Fosså Sophie D; Gail Mitchell; Travis Lois B
Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers.
Journal of the National Cancer Institute 2007;99(16):1248-56.
2007: Liavaag Astrid H; Dørum Anne; Fosså Sophie D; Tropé Claes; Dahl Alv A
Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2049-56.
2007: Fosså Sophie D; Gilbert Ethel; Dores Graça M; Chen Jinbo; McGlynn Katherine A; Schonfeld Sara; Storm Hans; Hall Per; Holowaty Eric; Andersen Aage; Joensuu Heikki; Andersson Michael; Kaijser Magnus; Gospodarowicz Mary; Cohen Randi; Pukkala Eero; Travis Lois B
Noncancer causes of death in survivors of testicular cancer.
Journal of the National Cancer Institute 2007;99(7):533-44.
2007: Thorsen Lene; Dahl Alv A; Skovlund Eva; Hornslien Kjersti; Fosså Sophie D
Effectiveness after 1 year of a short-term physical activity intervention on cardiorespiratory fitness in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(10):1301-2.
2007: Hodgson David C; Gilbert Ethel S; Dores Graça M; Schonfeld Sara J; Lynch Charles F; Storm Hans; Hall Per; Langmark Froydis; Pukkala Eero; Andersson Michael; Kaijser Magnus; Joensuu Heikki; Fosså Sophie D; Travis Lois B
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1489-97.
2007: Berg Arne; Berner Aasmund; Lilleby Wolfgang; Bruland Øyvind S; Fosså Sophie D; Nesland Jahn M; Kvalheim Gunnar
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.
International journal of cancer. Journal international du cancer 2007;120(8):1603-9.
2007: Wethal T; Kjekshus J; Røislien J; Ueland T; Andreassen A K; Wergeland R; Aukrust P; Fosså S D
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.
Journal of cancer survivorship : research and practice 2007;1(1):8-16.
2007: Edvardsen Hege; Kristensen Vessela N; Grenaker Alnaes Grethe Irene; Bøhn Mona; Erikstein Bjørn; Helland Aslaug; Børresen-Dale Anne-Lise; Fosså Sophie Dorothea
Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy.
International journal of radiation oncology, biology, physics 2007;67(4):1163-71.
2007: Haugnes H S; Aass N; Fosså S D; Dahl O; Klepp O; Wist E A; Svartberg J; Wilsgaard T; Bremnes R M
Components of the metabolic syndrome in long-term survivors of testicular cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):241-8.
2007: Vergouwe Yvonne; Steyerberg Ewout W; Foster Richard S; Sleijfer Dirk T; Fosså Sophie D; Gerl Arthur; de Wit Ronald; Roberts J Trevor; Habbema J Dik F
Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.
European urology 2007;51(2):424-32.
2007: Vistad Ingvild; Fosså Sophie D; Kristensen Gunnar B; Mykletun Arnstein; Dahl Alv A
The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample.
Journal of women's health (2002) 2007;16(1):139-48.
2007: Oldervoll Line M; Loge Jon H; Kaasa Stein; Lydersen Stian; Hjermstad Marianne J; Thorsen Lene; Holte Harald; Jacobsen Anne B; Fosså Sophie D
Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study.
BMC cancer 2007;7():210.
2007: Edvardsen Hege; Tefre Toril; Jansen Laila; Vu Phuong; Haffty Bruce G; Fosså Sophie D; Kristensen Vessela N; Børresen-Dale Anne-Lise
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence.
Radiation oncology (London, England) 2007;2():25.
2007: Gudbergsson Saevar Berg; Fosså Sophie D; Sanne Bjarte; Dahl Alv A
A controlled study of job strain in primary-treated cancer patients without metastases.
Acta oncologica (Stockholm, Sweden) 2007;46(4):534-44.
2007: Brydøy Marianne; Fosså Sophie D; Dahl Olav; Bjøro Trine
Gonadal dysfunction and fertility problems in cancer survivors.
Acta oncologica (Stockholm, Sweden) 2007;46(4):480-9.
2007: Fosså Sophie D; Hess Siri Lothe; Dahl Alv A; Hjermstad Marianne J; Veenstra Marijke
Stability of health-related quality of life in the Norwegian general population and impact of chronic morbidity in individuals with and without a cancer diagnosis.
Acta oncologica (Stockholm, Sweden) 2007;46(4):452-61.
2007: Nord Carina; Ganz Patricia A; Aziz Noreen; Fosså Sophie D
Follow-up of long-term cancer survivors in the Nordic countries.
Acta oncologica (Stockholm, Sweden) 2007;46(4):433-40.
2006: Oldenburg Jan; Martin Jarad M; Fosså Sophie D
Late relapses of germ cell malignancies: incidence, management, and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(35):5503-11.
2006: Jacobsen Kari Dolven; Fosså Sophie D; Aamdal Steinar
[Malignant melanoma--diagnosis and treatment]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(23):3094-7.
2006: Lilleby Wolfgang; Hernes Eivor; Waehre Håkon; Raabe Nils; Fosså Sophie D
[Treatment of hormone-resistant prostate cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(21):2798-801.
2006: Grov Ellen Karine; Fosså Sophie D; Sørebø Oystein; Dahl Alv A
Primary caregivers of cancer patients in the palliative phase: a path analysis of variables influencing their burden.
Social science & medicine (1982) 2006;63(9):2429-39.
2006: Schairer Catherine; Brown Linda Morris; Chen Bingshu E; Howard Regan; Lynch Charles F; Hall Per; Storm Hans; Pukkala Eero; Anderson Aage; Kaijser Magnus; Andersson Michael; Joensuu Heikki; Fosså Sophie D; Ganz Patricia A; Travis Lois B
Suicide after breast cancer: an international population-based study of 723,810 women.
Journal of the National Cancer Institute 2006;98(19):1416-9.
2006: Gudbergsson Saevar B; Fosså Sophie D; Borgeraas Elling; Dahl Alv A
A comparative study of living conditions in cancer patients who have returned to work after curative treatment.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(10):1020-9.
2006: Haukvik U K H; Dieset I; Bjøro T; Holte H; Fosså S D
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1428-33.
2006: Vistad Ingvild; Fosså Sophie D; Dahl Alv A
A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer.
Gynecologic oncology 2006;102(3):563-72.
2006: Grov Ellen Karine; Dahl Alv A; Fosså Sophie D; Wahl Astrid K; Moum Torbjørn
Global quality of life in primary caregivers of patients with cancer in palliative phase staying at home.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(9):943-51.
2006: Magelssen Henriette; Brydøy Marianne; Fosså Sophie D
The effects of cancer and cancer treatments on male reproductive function.
Nature clinical practice. Urology 2006;3(6):312-22.
2006: Oldenburg Jan; Fosså Sophie D; Dahl Alv A
Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(5):791-800.
2006: Grov Ellen Karine; Fosså Sophie D; Tønnessen Arnfinn; Dahl Alv A
The caregiver reaction assessment: psychometrics, and temporal stability in primary caregivers of Norwegian cancer patients in late palliative phase.
Psycho-oncology 2006;15(6):517-27.
2006: Sørlie Tore; Rosenvinge Jan H; Bremnes Roy; Balteskard Lise; Dahl Alv A; Klepp Olbjørn; Fosså Sophie D
Management satisfaction in survivors of testicular cancer.
Anticancer research 2006;26(2B):1463-9.
2006: Thorsen L; Nystad W; Stigum H; Hjermstad M; Oldervoll L; Martinsen E W; Hornslien K; Strømme S B; Dahl A A; Fosså S D
Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy.
The Journal of sports medicine and physical fitness 2006;46(1):122-7.
2006: Kvåle Rune; Skarre Elin; Tønne Andreas; Kyrdalen Anne E; Norstein Jarle; Angelsen Anders; Wahlqvist Rolf; Fosså Sophie D
[Curative treatment of prostatic cancer in Norway in 1998 and 2001]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(7):912-6.
2006: Oldenburg J; Alfsen G C; Waehre H; Fosså S D
Late recurrences of germ cell malignancies: a population-based experience over three decades.
British journal of cancer 2006;94(6):820-7.
2006: Schonfeld Sara J; Gilbert Ethel S; Dores Graça M; Lynch Charles F; Hodgson David C; Hall Per; Storm Hans; Andersen Aage; Pukkala Eero; Holowaty Eric; Kaijser Magnus; Andersson Michael; Joensuu Heikki; Fosså Sophie D; Allan James M; Travis Lois B
Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.
Journal of the National Cancer Institute 2006;98(3):215-8.
2006: Mykletun Arnstein; Dahl Alv A; O'Leary Michael P; Fosså Sophie D
Assessment of male sexual function by the Brief Sexual Function Inventory.
BJU international 2006;97(2):316-23.
2006: Hjermstad Marianne J; Oldervoll Line; Fosså Sophie D; Holte Harald; Jacobsen Anne B; Loge Jon H
Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.
European journal of cancer (Oxford, England : 1990) 2006;42(3):327-33.
2006: Christophersen Asbjørn O; Lie A Kathrine; Fosså Sophie D
Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 2006;45(2):226-8.
2005: Brydøy Marianne; Fosså Sophie D; Klepp Olbjørn; Bremnes Roy M; Wist Erik A; Wentzel-Larsen Tore; Dahl Olav
Paternity following treatment for testicular cancer.
Journal of the National Cancer Institute 2005;97(21):1580-8.
2005: Fosså S D; Paluchowska B; Horwich A; Kaiser G; de Mulder P H M; Koriakine O; van Oosterom A T; de Prijck L; Collette L; de Wit R;
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).
British journal of cancer 2005;93(11):1209-14.
2005: Magelssen H; Haugen T B; von Düring V; Melve K K; Sandstad B; Fosså S D
Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
European urology 2005;48(5):779-85.
2005: Torlakovic Emina; Lilleby Wolfgang; Berner Aasmund; Torlakovic Goran; Chibbar Rajni; Furre Torbjørn; Fosså Sophie D
Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma.
International journal of cancer. Journal international du cancer 2005;117(3):381-6.
2005: Fosså Sophie D; Wahlqvist Rolf
[Radical treatment of prostatic cancer in Norway]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(20):2834; author reply 2834-5.
2005: Fosså Sophie D
[Are all LH-RH analogues equally effective in prostate cancer?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(18):2493-5.
2005: Travis Lois B; Fosså Sophie D; Schonfeld Sara J; McMaster Mary L; Lynch Charles F; Storm Hans; Hall Per; Holowaty Eric; Andersen Aage; Pukkala Eero; Andersson Michael; Kaijser Magnus; Gospodarowicz Mary; Joensuu Timo; Cohen Randi J; Boice John D; Dores Graça M; Gilbert Ethel S
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Journal of the National Cancer Institute 2005;97(18):1354-65.
2005: Hjermstad Marianne J; Fosså Sophie D; Oldervoll Line; Holte Harald; Jacobsen Anne B; Loge Jon H
Fatigue in long-term Hodgkin's Disease survivors: a follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6587-95.
2005: Sagstuen H; Aass N; Fosså S D; Dahl O; Klepp O; Wist E A; Wilsgaard T; Bremnes R M
Blood pressure and body mass index in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4980-90.
2005: Thorsen Lene; Nystad Wenche; Stigum Hein; Dahl Olav; Klepp Olbjørn; Bremnes Roy M; Wist Erik; Fosså Sophie D
The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(8):637-46.
2005: Hernes E; Harvei S; Glattre E; Gjertsen F; Fosså S D
High prostate cancer mortality in Norway: influence of Cancer Registry information?
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(7-8):542-9.
2005: Fosså Sophie D; Chen Jinbo; Schonfeld Sara J; McGlynn Katherine A; McMaster Mary L; Gail Mitchell H; Travis Lois B
Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Journal of the National Cancer Institute 2005;97(14):1056-66.
2005: Skotheim Rolf I; Lind Guro E; Monni Outi; Nesland Jahn M; Abeler Vera M; Fosså Sophie D; Duale Nur; Brunborg Gunnar; Kallioniemi Olli; Andrews Peter W; Lothe Ragnhild A
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Cancer research 2005;65(13):5588-98.
2005: Grov E K; Dahl A A; Moum T; Fosså S D
Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1185-91.
2005: Lilleby Wolfgang; Fosså Sophie D
Chemotherapy in metastatic renal cell cancer.
World journal of urology 2005;23(3):175-9.
2005: Skarstein Jon; Bjelland Ingvar; Dahl Alv A; Laading Jacob; Fosså Sophie D
Is there an association between haemoglobin, depression, and anxiety in cancer patients?
Journal of psychosomatic research 2005;58(6):477-83.
2005: Nilsson Sten; Larsen Roy H; Fosså Sophie D; Balteskard Lise; Borch Kari W; Westlin Jan-Erik; Salberg Gro; Bruland Oyvind S
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4451-9.
2005: Røtterud Ranveig; Nesland Jahn Marthin; Berner Aasmund; Fosså Sophie D
Expression of the epidermal growth factor receptor family in normal and malignant urothelium.
BJU international 2005;95(9):1344-50.
2005: Dahl Alv A; Mykletun Arnstein; Fosså Sophie D
Quality of life in survivors of testicular cancer.
Urologic oncology 2005;23(3):193-200.
2005: Mykletun Arnstein; Dahl Alv A; Haaland Carl Fredrik; Bremnes Roy; Dahl Olav; Klepp Olbjørn; Wist Erik; Fosså Sophie D
Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3061-8.
2005: Dahl Alv A; Haaland Carl Fredrik; Mykletun Arnstein; Bremnes Roy; Dahl Olav; Klepp Olbjørn; Wist Erik; Fosså Sophie D
Study of anxiety disorder and depression in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2389-95.
2005: Thorsen Lene; Skovlund Eva; Strømme Sigmund B; Hornslien Kjersti; Dahl Alv A; Fosså Sophie D
Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2378-88.
2005: Lilleby Wolfgang; Sudbø Jon; Fosså Sophie D
[Biology and treatment options during the development of prostate cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(5):571-4.
2005: Aass Nina; Fosså Sophie D
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;74(3):259-65.
2005: Nord Carina; Mykletun Arnstein; Thorsen Lene; Bjøro Trine; Fosså Sophie D
Self-reported health and use of health care services in long-term cancer survivors.
International journal of cancer. Journal international du cancer 2005;114(2):307-16.
2005: Fosså Sophie D; Holte Harald; Holmen Marit Muri; Bjøro Trine; Langmark Frøydis; Hess Siri Lothe; Kvaløy Stein
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(1):41-4.
2005: Fosså Sophie D; Magelssen Henriette; Melve Kari; Jacobsen Anne B; Langmark Frøydis; Skjaerven Rolv
Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report.
Journal of the National Cancer Institute. Monographs 2005;(34):77-82.
2004: Norderhaug Inger N; Wisløff Torbjørn; Fosså Sophie; Sandberg Sverre; Malde Kjeld; Forland Frode; Førde Olav Helge
[Dissemination of evidence-based information about PSA test and prostatic cancer to physicians]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(22):2893-5.
2004: Schröder Fritz H; Kurth Karl Heinz; Fosså Sophie D; Hoekstra Wytze; Karthaus Peter P M; Debois Muriel; Collette Laurence;
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study.
The Journal of urology 2004;172(3):923-7.
2004: Fosså Sophie D; Mickisch Gerald H J; De Mulder Pieter H M; Horenblas Simon; van Oosterom Allan T; van Poppel Hein; Fey Martin; Croles Jelle J; de Prijck Linda; Van Glabbeke Martine
Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma.
Cancer 2004;101(3):533-40.
2004: Fosså Alexander; Berner Aasmund; Fosså Sophie D; Hernes Eivor; Gaudernack Gustav; Smeland Erlend B
NY-ESO-1 protein expression and humoral immune responses in prostate cancer.
The Prostate 2004;59(4):440-7.
2004: Stensvold E; Aass N; Gladhaug I; Stenwig A E; Claussen O P; Fosså S D
Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2004;30(3):352-5.
2004: Fosså S D; Aass N; Harvei S; Tretli S
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours.
British journal of cancer 2004;90(3):607-12.
2004: Hernes E; Fosså S D; Berner Aa; Otnes B; Nesland J M
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.
British journal of cancer 2004;90(2):449-54.
2004: Fosså S D; Magelssen H
Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv259-65.
2004: Fosså Sophie D
Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer.
Acta oncologica (Stockholm, Sweden) 2004;43(2):134-41.
2003: Skotheim Rolf I; Korkmaz Kemal S; Klokk Tove I; Abeler Vera M; Korkmaz Ceren G; Nesland Jahn M; Fosså Sophie D; Lothe Ragnhild A; Saatcioglu Fahri
NKX3.1 expression is lost in testicular germ cell tumors.
The American journal of pathology 2003;163(6):2149-54.
2003: Looijenga Leendert H J; de Leeuw Hubert; van Oorschot Monique; van Gurp Ruud J H L M; Stoop Hans; Gillis Ad J M; de Gouveia Brazao Carlos A; Weber Rob F A; Kirkels Wim J; van Dijk Thamar; von Lindern Marieke; Valk Peter; Lajos Geczy; Olah Edit; Nesland Jahn M; Fosså Sophie D; Oosterhuis J Wolter
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
Cancer research 2003;63(22):7674-8.
2003: Kraggerud Sigrid M; Lee Maxwell P; Skotheim Rolf I; Stenwig Anna E; Fosså Sophie D; Feinberg Andrew P; Lothe Ragnhild A
Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumors.
Cancer genetics and cytogenetics 2003;147(1):1-8.
2003: Skotheim Rolf I; Abeler Vera M; Nesland Jahn M; Fosså Sophie D; Holm Ruth; Wagner Urs; Flørenes Vivi Ann; Aass Nina; Kallioniemi Olli P; Lothe Ragnhild A
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.
Neoplasia (New York, N.Y.) 2003;5(5):397-404.
2003: Fosså S D; Aass N; Heilo A; Daugaard G; E Skakkebaek N; Stenwig A E; Nesland J M; Looijenga L H J; Oosterhuis J W
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1412-8.
2003: Nord Carina; Bjøro Trine; Ellingsen Dag; Mykletun Arnstein; Dahl Olav; Klepp Olbjørn; Bremnes Roy M; Wist Erik; Fosså Sophie D
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
European urology 2003;44(3):322-8.
2003: Fosså Sophie D; Lilleby Wolfgang; Waehre Håkon; Berner Aasmund; Torlakovic Goran; Paus Elisabeth; Olsen Dag Rune
Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy.
International journal of radiation oncology, biology, physics 2003;57(1):33-41.
2003: Rustøen Tone; Fosså Sophie D; Skarstein Jon; Moum Torbjørn
The impact of demographic and disease-specific variables on pain in cancer patients.
Journal of pain and symptom management 2003;26(2):696-704.
2003: Hvamstad Tor; Jordal Anders; Hekmat Nima; Paus Elisabeth; Fosså Sophie Dorothea
Neuroendocrine serum tumour markers in hormone-resistant prostate cancer.
European urology 2003;44(2):215-21.
2003: Smeland Sigbjørn; Erikstein Bjørn; Aas Magne; Skovlund Eva; Hess Siri Lothe; Fosså Sophie Dorothea
Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study.
International journal of radiation oncology, biology, physics 2003;56(5):1397-404.
2003: Thorsen L; Nystad W; Dahl O; Klepp O; Bremnes R M; Wist E; Fosså S D
The level of physical activity in long-term survivors of testicular cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(9):1216-21.
2003: Fosså Sophie D; Dahl Alv A; Loge Jon H
Fatigue, anxiety, and depression in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1249-54.
2003: Fosså Sophie D; de Wit Ronald; Roberts J Trevor; Wilkinson Peter M; de Mulder Pieter H M; Mead Graham M; Cook Pat; de Prijck Linda; Stenning Sally; Aaronson Neil K; Bottomley Andrew; Collette Laurence;
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1107-18.
2003: Guren M G; Dueland S; Skovlund E; Fosså S D; Poulsen J P; Tveit K M
Quality of life during radiotherapy for rectal cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(5):587-94.
2003: Nord C; Fosså S D; Egeland T
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer.
British journal of cancer 2003;88(1):36-41.
2003: Lilleby Wolfgang; Nesland Jahn M; Fosså Sophie D; Torlakovic Goran; Waehre Håkon; Kvalheim Gunnar
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer.
International journal of cancer. Journal international du cancer 2003;103(1):91-6.
2003: Hernes Eivor; Fosså Sophie D; Skovlund Eva
Androgen-independent prostate cancer--the clinical problem of a growing pelvic tumour.
Acta oncologica (Stockholm, Sweden) 2003;42(7):749-55.
2003: Norderhaug I N; Sandberg S; Fosså S D; Forland F; Malde K; Kvinnsland S; Traaholt I; Rossiné B K; Førde O H
Health technology assessment and implications for clinical practice: the case of prostate cancer screening.
Scandinavian journal of clinical and laboratory investigation 2003;63(5):331-8.
2003: Lilleby Wolfgang; Dale Einar; Olsen Dag R; Gude Unn; Fosså Sophie D
Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose.
Acta oncologica (Stockholm, Sweden) 2003;42(1):10-4.
2002: Smith-Sørensen B; Lind G E; Skotheim R I; Fosså S D; Fodstad Ø; Stenwig A-E; Jakobsen K S; Lothe R A
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer.
Oncogene 2002;21(57):8878-84.
2002: Nesvold Inger-Lise; Fosså Sophie D
[Lymphedema after surgical treatment of cervical and vulvar cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(26):2531-3.
2002: Jacobsen Kari Dolven; Fosså Sophie D; Bjøro Trine P; Aass Nina; Heilo Arne; Stenwig Anna E
Gonadal function and fertility in patients with bilateral testicular germ cell malignancy.
European urology 2002;42(3):229-38; discussion 237-8.
2002: Ustün Melek; Heilo Arne; Fosså Sophie; Aass Nina; Berner Aasmund
Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: diagnosis and therapeutic impact.
European urology 2002;42(3):221-8; discussion 228.
2002: Torlakovic Emina; Lilleby Wolfgang; Torlakovic Goran; Fosså Sophie D; Chibbar Rajni
Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score.
Human pathology 2002;33(6):646-51.
2002: Kraggerud Sigrid Marie; Skotheim Rolf I; Szymanska Jadwiga; Eknaes Mette; Fosså Sophie D; Stenwig Anna E; Peltomäki Päivi; Lothe Ragnhild A
Genome profiles of familial/bilateral and sporadic testicular germ cell tumors.
Genes, chromosomes & cancer 2002;34(2):168-74.
2002: Kvarstein Bernt; Fosså Sophie D; Harvei Sverre
[Diagnosis and treatment of penile cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(12):1194-7.
2002: Fosså Alexander; Lilleby Wolfgang; Fosså Sophie D; Gaudernack Gustav; Torlakovic Goran; Berner Aasmund
Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy.
International journal of cancer. Journal international du cancer 2002;99(1):100-5.
2002: Skotheim Rolf I; Monni Outi; Mousses Spyro; Fosså Sophie D; Kallioniemi Olli-P; Lothe Ragnhild A; Kallioniemi Anne
New insights into testicular germ cell tumorigenesis from gene expression profiling.
Cancer research 2002;62(8):2359-64.
2002: Fosså Sophie D; Vaage Sigmund; Letocha Henry; Iversen Jon; Risberg Terje; Johannessen Dag C; Paus Elisabeth; Smedsrud Trond;
Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered.
Scandinavian journal of urology and nephrology 2002;36(1):34-9.
2002: Fosså S D; Aass N; Winderen M; Börmer O P; Olsen D R
Long-term renal function after treatment for malignant germ-cell tumours.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):222-8.
2002: Fosså S D; Dahl A A
Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer.
Journal of psychosomatic research 2002;52(2):79-87.
2002: Kraggerud Sigrid Marie; Aman Pierre; Holm Ruth; Stenwig Anna Elisabeth; Fosså Sophie Dorothea; Nesland Jahn M; Lothe Ragnhild A
Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
Cancer research 2002;62(2):512-7.
2002: Skarstein Jon; Dahl Alv A; Laading Jacob; Fosså Sophie D
'Patient satisfaction' in hospitalized cancer patients.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):639-45.
2002: Røtterud Ranveig; Pettersen Erik O; Berner Aasmund; Holm Ruth; Olsen Dag Rune; Fosså Sophie D
Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients.
Acta oncologica (Stockholm, Sweden) 2002;41(5):463-70.
2002: Fosså Sophie D; Skovlund Eva
Selection of patients may limit the generalizability of results from cancer trials.
Acta oncologica (Stockholm, Sweden) 2002;41(2):131-7.
2001: Guren M G; Wiig J N; Dueland S; Tveit K M; Fosså S D; Waehre H; Giercksky K E
Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001;27(7):645-51.
2001: Røtterud R; Berner A; Holm R; Skovlund E; Fosså S D
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder.
BJU international 2001;88(3):202-8.
2001: Lilleby W; Torlakovic G; Torlakovic E; Skovlund E; Fosså S D
Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy.
Cancer 2001;92(2):311-9.
2001: Skotheim R I; Kraggerud S M; Fosså S D; Stenwig A E; Gedde-Dahl T; Danielsen H E; Jakobsen K S; Lothe R A
Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence.
Neoplasia (New York, N.Y.) 2001;3(3):196-203.
2001: de Wit R; Roberts J T; Wilkinson P M; de Mulder P H; Mead G M; Fosså S D; Cook P; de Prijck L; Stenning S; Collette L
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1629-40.
2001: Lilleby W; Paus E; Skovlund E; Fosså S D
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer.
The Prostate 2001;46(2):126-33.
2001: Fosså S D; Slee P H; Brausi M; Horenblas S; Hall R R; Hetherington J W; Aaronson N; de Prijck L; Collette L
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):62-71.
2001: Røtterud R; Skomedal H; Berner A; Danielsen H E; Skovlund E; Fosså S D
TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy.
Acta oncologica (Stockholm, Sweden) 2001;40(5):644-52.
2000: Jacobsen K D; Fosså S D
Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle.
European urology 2000;38(6):725-6;discussion 727.
2000: Lilleby W; Fosså S D; Knutsen B H; Abildgaard A; Skovlund E; Lien H H
Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;57(2):195-200.
2000: Skovlund E; Fosså S D
[PSA analyses in three Norwegian counties in 1999]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2000;120(21):2539-41.
2000: Fosså A; Siebert R; Aasheim H C; Maelandsmo G M; Berner A; Fosså S D; Paus E; Smeland E B; Gaudernack G
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer.
British journal of cancer 2000;83(6):743-9.
2000: Hernes E H; Linja M; Fosså S D; Visakorpi T; Berner A; Winderen M; Koivisto P A
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.
BJU international 2000;86(3):240-7.
2000: Skarstein J; Aass N; Fosså S D; Skovlund E; Dahl A A
Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire.
Journal of psychosomatic research 2000;49(1):27-34.
2000: Hernandez A M; Fosså S D; Brøgger A; Kat A; Skovlund E
Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):897-8.
2000: Fosså S D; Curran D; Aaronson N K; Keuppens F; Kliment J; Robinson M R; DeReijke T M; Hetherington J; Kil P J; Rea L A
Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.
European urology 2000;37(5):541-51.
2000: Fosså S D; Kravdal O
Fertility in Norwegian testicular cancer patients.
British journal of cancer 2000;82(3):737-41.
2000: Cappelen T; Fosså S D; Stenwig A E; Aass N
False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer.
Acta oncologica (Stockholm, Sweden) 2000;39(1):105-9.
1999: Fosså S D; Eri L M
[Timely screening routines for prostatic cancer by Norwegian physicians]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1999;119(24):3572-6.
1999: Fosså S D; Dahl A A; Haaland C F
Health-related quality of life in patients treated for testicular cancer.
Current opinion in urology 1999;9(5):425-9.
1999: Fosså S D; Opjordsmoen S; Haug E
Androgen replacement and quality of life in patients treated for bilateral testicular cancer.
European journal of cancer (Oxford, England : 1990) 1999;35(8):1220-5.
1999: Fosså S D; Stenning S P; Gerl A; Horwich A; Clark P I; Wilkinson P M; Jones W G; Williams M V; Oliver R T; Newlands E S; Mead G M; Cullen M H; Kaye S B; Rustin G J; Cook P A
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
British journal of cancer 1999;80(9):1392-9.
1999: Fosså S D; Horwich A; Russell J M; Roberts J T; Cullen M H; Hodson N J; Jones W G; Yosef H; Duchesne G M; Owen J R; Grosch E J; Chetiyawardana A D; Reed N S; Widmer B; Stenning S P
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1146.
1999: Jacobsen K D; Ous S; Waehre H; Trasti H; Stenwig A E; Lien H H; Aass N; Fosså S D
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.
British journal of cancer 1999;80(1-2):249-55.
1999: Lilleby W; Fosså S D; Waehre H R; Olsen D R
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
International journal of radiation oncology, biology, physics 1999;43(4):735-43.
1999: Fosså S D; Bokemeyer C; Gerl A; Culine S; Jones W G; Mead G M; Germa-Luch J R; Pont J; Schmoll H J; Tjulandin S
Treatment outcome of patients with brain metastases from malignant germ cell tumors.
Cancer 1999;85(4):988-97.
1999: Dale E; Olsen D R; Fosså S D
Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy.
International journal of radiation oncology, biology, physics 1999;43(2):385-91.
1998: Wanderås E H; Grotmol T; Fosså S D; Tretli S
Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995.
Cancer causes & control : CCC 1998;9(5):475-86.
1998: Otnes B; Hernes E; Fosså S D
[Prostate-specific antigen in the follow-up of conservatively treated prostatic cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(22):3401-5.
1998: Fosså S D; Aass N; Parö G
A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma.
European journal of cancer (Oxford, England : 1990) 1998;34(7):1131-2.
1998: Osen I; Fosså S D; Majak B; Røtterud R; Berner A
Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study.
British journal of urology 1998;81(6):862-9.
1998: Avizienyte E; Roth S; Loukola A; Hemminki A; Lothe R A; Stenwig A E; Fosså S D; Salovaara R; Aaltonen L A
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors.
Cancer research 1998;58(10):2087-90.
1998: Paus E; Nilsson O; Børmer O P; Fosså S D; Otnes B; Skovlund E
Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
The Journal of urology 1998;159(5):1599-605.
1998: Aass N; Fosså S D; Dahl A A; Moe T J
[Occurrence of anxiety and depression in cancer patients. An investigation at the Norwegian Radium Hospital]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(5):698-703.
1998: Fosså S D; Kaye S B; Mead G M; Cullen M; de Wit R; Bodrogi I; van Groeningen C J; De Mulder P H; Stenning S; Lallemand E; De Prijck L; Collette L
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):716-24.
1998: Dueland S; Stenwig A E; Heilo A; Høie J; Ous S; Fosså S D
Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.
British journal of cancer 1998;77(2):329-35.
1997: Aass N; Håtun D E; Thoresen M; Fosså S D
Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(2):125-8.
1997: Raabe N K; Fosså S D; Kåresen R
[Primary invasive breast cancer in Oslo 1980-89. A population based study of 1942 unselected patients treated by radical surgery]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(26):3778-83.
1997: Herlofson B B; Norman-Pedersen K; Redfors M; Fosså S D
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
European journal of oral sciences 1997;105(5 Pt 2):523-6.
1997: Aass N; Fosså S D; Dahl A A; Moe T J
Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital.
European journal of cancer (Oxford, England : 1990) 1997;33(10):1597-604.
1997: Fosså S D; Oliver R T; Stenning S P; Horwich A; Wilkinson P; Read G; Mead G M; Roberts J T; Rustin G; Cullen M H; Kaye S B; Harland S J; Cook P
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.
European journal of cancer (Oxford, England : 1990) 1997;33(9):1380-7.
1997: Fosså S D; De Angelis P; Kraggerud S M; Evenson D; Theodorsen L; Clausen O P
Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin structure assay.
Cytometry 1997;30(4):192-6.
1997: Duchesne G M; Stenning S P; Aass N; Mead G M; Fosså S D; Oliver R T; Horwich A; Read G; Roberts I T; Rustin G; Cullen M H; Kaye S B; Harland S J; Cook P A
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.
European journal of cancer (Oxford, England : 1990) 1997;33(6):829-35.
1997: Horwich A; Sleijfer D T; Fosså S D; Kaye S B; Oliver R T; Cullen M H; Mead G M; de Wit R; de Mulder P H; Dearnaley D P; Cook P A; Sylvester R J; Stenning S P
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1844-52.
1997: Jacobsen K D; Olsen D R; Fosså K; Fosså S D
External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis.
International journal of radiation oncology, biology, physics 1997;38(1):95-102.
1997: Wanderås E H; Fosså S D; Tretli S
Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients.
European journal of cancer (Oxford, England : 1990) 1997;33(2):253-62.
1997: Wanderås E H; Fosså S D; Tretli S
Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients.
European journal of cancer (Oxford, England : 1990) 1997;33(2):244-52.
1997: Kraggerud S M; Jacobsen K D; Berner A; Stokke T; Holm R; Smedshammer L; Børresen-Dale A L; Fosså S D
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer.
Pathology, research and practice 1997;193(7):471-8.
1997: Hernes E H; Fosså S D; Vaage S; Ogreid P; Heilo A; Paus E
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
British journal of cancer 1997;76(1):93-9.
1997: Raabe N K; Kaaresen R; Fosså S D
Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma--a pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980-1989.
Acta oncologica (Stockholm, Sweden) 1997;36(3):255-60.
1997: Fosså S D; Woehre H; Kurth K H; Hetherington J; Bakke H; Rustad D A; Skånvik R
Influence of urological morbidity on quality of life in patients with prostate cancer.
European urology 1997;31 Suppl 3():3-8.
1997: Fosså S D
Residual androgen depending in hormone-resistant prostate cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(1):81-2.
1997: Heimdal K; Olsson H; Tretli S; Fosså S D; Børresen A L; Bishop D T
A segregation analysis of testicular cancer based on Norwegian and Swedish families.
British journal of cancer 1997;75(7):1084-7.
1997: Hollender A; Stenwig E A; Ous S; Fosså S D
Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy.
European urology 1997;31(2):141-7.
1996: Fosså S D
Quality of life in advanced prostate cancer.
Seminars in oncology 1996;23(6 Suppl 14):32-4.
1996: Fosså S D; Sternberg C; Scher H I; Theodore C H; Mead B; Dearnaley D; Roberts J T; Skovlund E
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy.
British journal of cancer 1996;74(10):1655-9.
1996: Semb K A; Aamdal S; Fosså S D; Oian P
Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
Journal of experimental therapeutics & oncology 1996;1(3):155-61.
1996: Braendengen M; Winderen M; Fosså S D
Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer.
British journal of urology 1996;77(1):36-40.
1996: Fosså S D
Quality of life in prostate cancer: what are the issues and how are they measured?
European urology 1996;29 Suppl 2():121-3.
1995: Wanderås E H; Tretli S; Fosså S D
Trends in incidence of testicular cancer in Norway 1955-1992.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):2044-8.
1995: Lothe R A; Peltomäki P; Tommerup N; Fosså S D; Stenwig A E; Børresen A L; Nesland J M
Molecular genetic changes in human male germ cell tumors.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):606-14.
1995: Fosså S D; Lehne G; Heimdal K; Theodorsen L
Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer.
Oncology 1995;52(4):300-5.
1995: Josefsen D; Waehre H; Paus E; Fosså S D
Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancer.
British journal of urology 1995;75(4):502-6.
1995: Fosså S D; Droz J P; Stoter G; Kaye S B; Vermeylen K; Sylvester R
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
British journal of cancer 1995;71(3):619-24.
1995: Heimdal K; Andersen T I; Skrede M; Fosså S D; Berg K; Børresen A L
Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(2):123-6.
1995: Berner A; Waere H; Nesland J M; Paus E; Danielsen H E; Fosså S D
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
British journal of urology 1995;75(1):26-32.
1995: Fosså S D; Aamdal S; Naume B; Gallati H
Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy.
Acta oncologica (Stockholm, Sweden) 1995;34(5):599-603.
1994: Fosså S D; Jacobsen A B; Aass N; Heilo A; Stenwig A E; Kummen O; Johannessen N B; Waaler G; Ogreid P; Borge L
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
British journal of cancer 1994;70(6):1156-60.
1994: Fosså S D; Aass N; Opjordsmoen S
Assessment of quality of life in patients with prostate cancer.
Seminars in oncology 1994;21(5):657-61.
1994: Fosså S D; Silde J; Theodorsen L; Pettersen E O
Pre-treatment DNA ploidy of sperm cells as a predictive parameter of post-treatment spermatogenesis in patients with testicular cancer.
British journal of urology 1994;74(3):359-65.
1994: Fosså S D
Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience.
British journal of urology 1994;74(3):345-51.
1994: Heimdal K R; Lothe R A; Fosså S D; Børresen A L
Association studies of a polymorphism in the Wilms' tumor 1 locus in Norwegian patients with testicular cancer.
International journal of cancer. Journal international du cancer 1994;58(4):523-6.
1994: Berner A; Harvei S; Tretli S; Fosså S D; Nesland J M
Prostatic carcinoma: a multivariate analysis of prognostic factors.
British journal of cancer 1994;69(5):924-30.
1994: Jacobsen K D; Follerås G; Fosså S D
Metastases from renal cell carcinoma to the humerus or the shoulder girdle.
British journal of urology 1994;73(2):124-8.
1994: Fosså S D; Kramar A; Droz J P
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1310-4.
1994: Fosså S D; Wanderås E H; Heimdal K
Second cancer after treatment of malignant germ-cell tumors.
World journal of urology 1994;12(3):151-4.
1994: Heimdal K; Fosså S D
Genetic factors in malignant germ-cell tumors.
World journal of urology 1994;12(4):178-81.
1994: Bjerkehagen B; Fosså S D; Raabe N; Holm R; Nesland J M
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
European urology 1994;26(4):334-9.
1994: Fosså S D; Paus E
Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary report.
European urology 1994;26(1):29-34.
1993: Berner A; Danielsen H E; Juul N O; Juul M E; Pettersen E O; Reith A; Nesland J M; Fosså S D
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1993;5(6):339-52.
1993: Waehre H; Ous S; Klevmark B; Kvarstein B; Urnes T; Ogreid P; Johansen T E; Fosså S D
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.
Cancer 1993;72(10):3044-51.
1993: Fosså S D; Waehre H; Aass N; Jacobsen A B; Olsen D R; Ous S
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients.
Cancer 1993;72(10):3036-43.
1993: Fosså S D; Berner A A; Jacobsen A B; Waehre H; Kvarstein B; Urnes T; Ogreid P; Johansen T E; Silde J; Nesland J M
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.
British journal of cancer 1993;68(3):572-8.
1993: Lehne G; Johansen B; Fosså S D
Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin.
British journal of cancer 1993;68(3):555-8.
1993: Berner A; Danielsen H E; Pettersen E O; Fosså S D; Reith A; Nesland J M
DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1993;15(4):247-52.
1993: Berner A; Nesland J M; Waehre H; Silde J; Fosså S D
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
British journal of cancer 1993;68(2):380-4.
1993: Lothe R A; Hastie N; Heimdal K; Fosså S D; Stenwig A E; Børresen A L
Frequent loss of 11p13 and 11p15 loci in male germ cell tumours.
Genes, chromosomes & cancer 1993;7(2):96-101.
1993: Aass N; Grünfeld B; Kaalhus O; Fosså S D
Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation.
British journal of cancer 1993;67(5):1113-7.
1993: Hannisdal E; Fosså S D; Høst H
Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;27(2):117-22.
1993: Ottestad L; Pettersen E O; Nesland J M; Hannisdal E; Fosså S D; Tveit K M
Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Pathology, research and practice 1993;189(4):405-10.
1993: Fosså S D; Winderen M
Does decreased skeletal uptake of 99mTc-methylene bisphosphonate in irradiated bone indicate the absence of bone metastases?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;27(1):63-5.
1993: Berner A; Jacobsen A B; Fosså S D; Nesland J M
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Histopathology 1993;22(4):327-33.
1993: Josefsen D; Ous S; Høie J; Stenwig A E; Fosså S D
Salvage treatment in male patients with germ cell tumours.
British journal of cancer 1993;67(3):568-72.
1993: Heikkilä R; Heilo A; Stenwig A E; Fosså S D
Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours.
British journal of urology 1993;71(2):214-6.
1993: Heimdal K; Lothe R A; Lystad S; Holm R; Fosså S D; Børresen A L
No germline TP53 mutations detected in familial and bilateral testicular cancer.
Genes, chromosomes & cancer 1993;6(2):92-7.
1993: Fosså S D; Aabyholm T; Vespestad S; Norman N; Ous S
Semen quality after treatment for testicular cancer.
European urology 1993;23(1):172-6.
1993: Harland S J; Cook P A; Fosså S D; Horwich A; Parkinson M C; Roberts J T; Stenning S P
Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report.
European urology 1993;23(1):115-8; discussion 119.
1993: Blomlie V; Lehne G; Lien H H; Winderen M; Fosså S D
Meningeal tumour infiltration in hormone resistant prostate cancer demonstrated with magnetic resonance.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1357.
1993: Fosså S D; Aune H; Baggerud E; Granerud T; Heilo A; Theodorsen L
Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1313-5.
1992: Waehre H; Amellem O; Stenwig A E; Tverå K; Juul M; Pettersen E O; Fosså S D
Deoxyribonucleic acid cytometry and histological findings before and after 125iodine implantation of primary prostate cancer.
The Journal of urology 1992;148(3):838-41; discussion 841-2.
1992: Qvist H; Fosså S D; Ous S; Lien H H; Stenwig A E; Giercksky K E
Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor.
Journal of surgical oncology 1992;50(4):220-3.
1992: Fosså S D; Harland S J; Kaye S B; Raghavan D; Russell J M; Parmar M K; Uscinska B M; Wood R
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).
British journal of urology 1992;70(2):161-8.
1992: Fosså S D; Waehre H; Paus E
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
British journal of cancer 1992;66(1):181-4.
1992: Fosså S D; Paus E; Lochoff M; Backe S M; Aas M
89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes.
British journal of cancer 1992;66(1):177-80.
1992: Fosså S D; Dearnaley D P; Law M; Gad J; Newling D W; Tveter K
Prognostic factors in hormone-resistant progressing cancer of the prostate.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(5):361-6.
1992: Fosså S D; Martinelli G; Otto U; Schneider G; Wander H; Oberling F; Bauer H W; Achtnicht U; Holdener E E
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(4):301-5.
1992: Fosså S D; Lehne G; Gunderson R; Hjelmaas U; Holdener E E
Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies.
International journal of cancer. Journal international du cancer 1992;50(6):868-70.
1992: Fosså S D; Qvist H; Stenwig A E; Lien H H; Ous S; Giercksky K E
Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):569-73.
1992: Lothe R A; Heimdal K; Lier M E; Fosså S D; Møller P; Brøgger A
High resolution chromosome banding in search of germ line mutations applied on testicular cancer patients.
Cancer genetics and cytogenetics 1992;59(1):62-7.
1992: Fosså S D; Klepp O; Paus E
Neuron-specific enolase--a serum tumour marker in seminoma?
British journal of cancer 1992;65(2):297-9.
1992: Heier M S; Aass N; Ous S; Fosså S D
Asymmetrical autonomic dysfunction of the feet after retroperitoneal surgery in patients with testicular cancer: 2 case reports.
The Journal of urology 1992;147(2):470-1.
1992: Fosså S D; Paus E; Lindegaard M; Newling D W
Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment.
British journal of urology 1992;69(2):175-9.
1992: Jacobsen A B; Pettersen E O; Amellem O; Berner A; Ous S; Fosså S D
The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy.
The Journal of urology 1992;147(1):34-7.
1992: Fosså S D; Ous S; Espetveit S; Langmark F
Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer.
Scandinavian journal of urology and nephrology 1992;26(2):131-8.
1992: Aass N; Fosså S D; Høst H
Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study.
International journal of radiation oncology, biology, physics 1992;22(5):1057-64.
1992: Fosså S D; Berner A; Waehre H; Heiden T; Juul M E; van den Ouden D; Pettersen E O; Wang N; Tribukait B
DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories.
Cytometry 1992;13(4):395-403.
1992: Fosså S D; Droz J P; Pavone-Macaluso M M; Debruyne F J; Vermeylen K; Sylvester R
Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):878-80.
1992: Jacobsen A B; Berner A; Juul M; Ous S; Pettersen E O; Fosså S D
DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report.
European urology 1992;22(4):316-22.
1992: Waehre H; Wanderaas E H; Paus E; Fosså S D
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
European urology 1992;22(1):33-8.
1991: Fosså S D; Nesland J M; Pettersen E O; Amellem O; Waehre H; Heimdal K
DNA ploidy in primary testicular cancer.
British journal of cancer 1991;64(5):948-52.
1991: Heimdal K; Evensen S A; Fosså S D; Hirscberg H; Langholm R; Brøgger A; Møller P
Karyotyping of a hematologic neoplasia developing shortly after treatment for cerebral extragonadal germ cell tumor.
Cancer genetics and cytogenetics 1991;57(1):41-6.
1991: Lindegaard M W; Aass N; Bue E S; Theodorsen L; Fosså S D
Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patients.
British journal of cancer 1991;64(2):401-5.
1991: Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså S D
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):818-26.
1991: Heier M S; Nilsen T; Graver V; Aass N; Fosså S D
Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.
British journal of cancer 1991;63(4):550-2.
1991: Fosså S D; Nesland J M; Waehre H; Amellem O; Pettersen E O
DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I.
Cancer 1991;67(7):1874-7.
1991: Blomlie V; Lien H H; Fosså S D; Jacobsen A B; Stenwig A E
CT in primary malignant germ cell tumors of the retroperitoneum.
Acta radiologica (Stockholm, Sweden : 1987) 1991;32(2):155-8.
1991: Qvist H L; Fosså S D; Ous S; Høie J; Stenwig A E; Giercksky K E
Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
The Journal of urology 1991;145(2):300-2; discussion 302-3.
1991: Fosså S D; Ous S; Berner A
Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy.
British journal of urology 1991;67(1):54-60.
1991: Fosså S D; Melvik J E; Juul N O; Pettersen E O; Amellem O; Theodorsen L
DNA flow cytometry in sperm cells from testicular cancer patients. Impact of different treatment modalities on spermatogenesis.
European urology 1991;19(2):125-31.
1991: Fosså S D; Hosbach G
Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect.
Acta oncologica (Stockholm, Sweden) 1991;30(6):735-8.
1991: Aass N; Fosså S D; Theodorsen L; Norman N
Prediction of long-term gonadal toxicity after standard treatment for testicular cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(9):1087-91.
1991: Kaasa S; Aass N; Mastekaasa A; Lund E; Fosså S D
Psychosocial well-being in testicular cancer patients.
European journal of cancer (Oxford, England : 1990) 1991;27(9):1091-5.
1990: Fosså S D; Hosbach G; Paus E
Flutamide in hormone-resistant prostatic cancer.
The Journal of urology 1990;144(6):1411-4.
1990: Sager E M; Fosså S D; Kaalhus O; Tveit K M
Computed tomography of the urinary bladder shortly after radiation therapy for rectal carcinoma.
Acta radiologica (Stockholm, Sweden : 1987) 1990;31(6):585-8.
1990: Fosså S D; Haug E
Serum levels of sex hormone binding globulin and oestradiol in patients with testicular cancer.
British journal of urology 1990;66(5):518-22.
1990: Aass N; Fosså S D; Aas M; Lindegaard M W
Renal function related to different treatment modalities for malignant germ cell tumours.
British journal of cancer 1990;62(5):842-6.
1990: Abrahamsen J F; Fosså S D
Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1990;166(9):580-3.
1990: Wanderas E H; Fosså S D; Heilo A; Stenwig A E; Norman N
Serum follicle stimulating hormone--predictor of cancer in the remaining testis in patients with unilateral testicular cancer.
British journal of urology 1990;66(3):315-7.
1990: Fosså S D; Theodorsen L; Norman N; Aabyholm T
Recovery of impaired pretreatment spermatogenesis in testicular cancer.
Fertility and sterility 1990;54(3):493-6.
1990: Heimdal K; Fosså S D; Johansen A
Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-1987.
British journal of cancer 1990;62(2):277-8.
1990: Klepp O; Flodgren P; Maartman-Moe H; Lindholm C E; Unsgaard B; Teigum H; Fosså S D; Paus E
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(4):281-8.
1990: Fosså S D; Gunderson R; Moe B
Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.
Cancer 1990;65(11):2451-4.
1990: Aass N; Fosså S D; Ous S; Lien H H; Stenwig A E; Paus E; Kaalhus O
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
British journal of urology 1990;65(4):385-90.
1990: Jacobsen A B; Nesland J M; Fosså S D; Pettersen E O
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.
The Journal of urology 1990;143(4):706-9.
1990: Borge N; Fosså S D; Stenwig A E
Metastatic testicular cancer and extragonadal germ cell tumor presenting with neurological symptoms.
Journal of neuro-oncology 1990;8(2):145-8.
1990: Fosså S D; Langmark F; Aass N; Andersen A; Lothe R; Børresen A L
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
British journal of cancer 1990;61(4):639-43.
1990: Aass N; Fosså S D; Ous S; Stenwig A E; Lien H H; Paus E; Kaalhus O
Prognosis in patients with metastatic non-seminomatous testicular cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;17(4):285-92.
1990: Fosså S D; Heilo A; Børmer O
Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug.
The Journal of urology 1990;143(3):498-501.
1990: Klepp O; Olsson A M; Henrikson H; Aass N; Dahl O; Stenwig A E; Persson B E; Cavallin-Ståhl E; Fosså S D; Wahlqvist L
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):509-18.
1990: Aass N; Kaasa S; Lund E; Kaalhus O; Heier M S; Fosså S D
Long-term somatic side-effects and morbidity in testicular cancer patients.
British journal of cancer 1990;61(1):151-5.
1990: Fosså S D; Nesland J M; Melvik J E; Jacobsen A B; Moe B
Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 1990;29(3):303-6.
1990: Fosså S D; Sager E M; Hosbach G; Waehre H; Ous S
Cisplatin and medium dose methotrexate in advanced transitional cell carcinoma of the urinary tract.
Scandinavian journal of urology and nephrology 1990;24(3):199-204.
1990: Fosså S D; Kreuser E D; Roth G J; Raghavan D
Long-term side effects after treatment of testicular cancer.
Progress in clinical and biological research 1990;357():321-30.
1990: Fosså S D; Ous S; Stenwig A E; Lien H H; Aass N; Kaalhus O
Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
European urology 1990;17(2):107-12.
1990: Fosså S D; Saeter G; Aass N; Ous S; Stenwig A E; Blomlie V
Management of patients with poor-prognosis nonseminomatous germ cell cancer.
Oncology 1990;47(3):234-40.
1989: Tveit K M; Karlsen K O; Fosså S D; Flokkmann A; Guldvog I; Haffner J
Primary treatment of carcinoma of the anus by combined radiotherapy and chemotherapy.
Scandinavian journal of gastroenterology 1989;24(10):1243-7.
1989: Jacobsen A B; Lunde S; Ous S; Melvik J E; Pettersen E O; Kaalhus O; Fosså S D
T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values.
International journal of radiation oncology, biology, physics 1989;17(5):923-9.
1989: Fosså S D; Kullmann G; Lien H H; Stenwig A E; Ous S
Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment.
British journal of urology 1989;64(5):530-4.
1989: Fosså S D; Aass N; Molne K
Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
British journal of urology 1989;64(5):524-9.
1989: Fosså S D; Raabe N; Moe B
Recombinant interferon-alpha with or without vinblastine in metastatic renal carcinoma. Results of a randomised phase II study.
British journal of urology 1989;64(5):468-71.
1989: Fosså S D; Aass N; Ous S; Høie J; Stenwig A E; Lien H H; Paus E; Kaalhus O
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
The Journal of urology 1989;142(5):1239-42.
1989: Lothe R A; Fosså S D; Stenwig A E; Nakamura Y; White R; Børresen A L; Brøgger A
Loss of 3p or 11p alleles is associated with testicular cancer tumors.
Genomics 1989;5(1):134-8.
1989: Fosså S D; Aass N; Kaalhus O
Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer.
Cancer 1989;64(2):404-8.
1989: Fosså S D; Melvik J E; Juul N O; Pettersen E O; Theodorsen L
DNA flow cytometry in sperm cells from unilaterally orchiectomized patients with testicular cancer before further treatment.
Cytometry 1989;10(3):345-50.
1989: Fosså S D; Aass N
Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer.
British journal of urology 1989;63(5):531-4.
1989: Abildgaard A; Lien H H; Fosså S D; Høie J; Langholm R
Enlargement of the thymus following chemotherapy for non-seminomatous testicular cancer.
Acta radiologica (Stockholm, Sweden : 1987) 1989;30(3):259-62.
1989: Fosså A; Fosså S D
Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
British journal of urology 1989;63(4):408-15.
1989: Fosså S D; Ous S; Lien H H; Stenwig A E
Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
The Journal of urology 1989;141(3):557-9.
1989: Fosså S D; Aass N; Kaalhus O
Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients.
International journal of radiation oncology, biology, physics 1989;16(2):383-8.
1989: Fosså S D; Splinter T; Roozendaal K J; Veenhof K H; Pavone-Macaluso M; Calciati A; de Pauw M; Sylvester R
A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.
European journal of cancer & clinical oncology 1989;25(2):389-90.
1989: Aass N; Fosså S D; Otto F; Ose T
Acute subjective morbidity after cisplatin-based combination chemotherapy in patients with testicular cancer: a prospective study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;14(1):27-33.
1989: Fosså S D; Stenwig A E; Lien H H; Ous S; Kaalhus O
Non-seminomatous testicular cancer clinical stage I: prediction of outcome by histopathological parameters. A multivariate analysis.
Oncology 1989;46(5):297-300.
1989: Fosså S D; Aaronson N; Calais da Silva F; Denis L; Newling D; Hosbach G; Kaalhus O
Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer.
European urology 1989;16(5):335-9.
1988: Fosså S D; Klepp O; Norman N
Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer.
British journal of urology 1988;62(5):449-53.
1988: Lien H H; Lindsköld L; Fosså S D; Aass N
Computed tomography and conventional radiography in intrathoracic metastases from non-seminomatous testicular tumor.
Acta radiologica (Stockholm, Sweden : 1987) 1988;29(5):547-9.
1988: Fosså S D; Aass N; Kaalhus O
Testicular cancer in young Norwegians.
Journal of surgical oncology 1988;39(1):43-63.
1988: Borge N; Fosså S D; Ous S; Stenwig A E; Lien H H
Late recurrence of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(8):1248-53.
1988: Sager E M; Talle K; Lindsköld L; Fosså S D; Kaalhus O; Johannessen N B; Ous S
Computed tomography of invasive bladder carcinoma after diagnostic transurethral resection.
Acta radiologica (Stockholm, Sweden : 1987) 1988;29(4):435-9.
1988: Svare A; Fosså S D; Heier M S
Cranial nerve dysfunction in metastatic cancer of the prostate.
British journal of urology 1988;61(5):441-4.
1988: Blomlie V; Lien H H; Fosså S D; Jacobsen A B; Stenwig A E
Computed tomography in primary non-seminomatous germ cell tumors of the mediastinum.
Acta radiologica (Stockholm, Sweden : 1987) 1988;29(3):289-92.
1988: Paus E; Fosså A; Fosså S D; Nustad K
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma.
The Journal of urology 1988;139(3):542-4.
1988: Jacobsen A B; Fosså S D; Thorud E; Lunde S; Melvik J E; Pettersen E O
DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1988;96(1):25-9.
1988: Sager E M; Fosså S D; Ous S; Johannessen N
Evaluation of response by CT in patients with advanced bladder cancer treated with cisplatinum/methotrexate.
Progress in clinical and biological research 1988;260():499-510.
1988: Fosså S D; Miller A; Ous S; Poppe E; Host H; Kaalhus O
Treatment of muscle-infiltrating bladder cancer: the Norwegian Radium Hospital's experience 1966-1982.
Progress in clinical and biological research 1988;260():525-41.
1988: Fosså S D
Is interferon with or without vinblastine the "treatment of choice" in metastatic renal cell carcinoma? The Norwegian Radium Hospital's experience 1983-1986.
Seminars in surgical oncology 1988;4(3):178-83.
1988: Jacobsen A B; Thorud E; Fosså S D; Lunde S; Shoaib M C; Juul N O; Pettersen E O
DNA flow cytometry in metastases and a recurrency of malignant melanomas. A comparison of results from fresh and paraffin embedded material.
Virchows Archiv. B, Cell pathology including molecular pathology 1988;54(5):273-7.
1988: Aass N; Fosså S D
Paternity in young patients with testicular cancer--expectations and experience.
Progress in clinical and biological research 1988;269():481-91.
1988: Heimdal K; Hannisdal E; Fosså S D
Survival after palliative radiotherapy of liver metastases. A search for prognostic factors.
Acta oncologica (Stockholm, Sweden) 1988;27(1):63-5.
1987: Evensen J F; Fosså S D; Kjellevold K; Lien H H
Testicular seminoma: histological findings and their prognostic significance for stage II disease.
Journal of surgical oncology 1987;36(3):166-9.
1987: Jacobsen A B; Fosså S D; Lunde S; Melvik J E; Pettersen E O
Flow cytometric DNA measurements in paraffin-embedded bladder carcinoma tissue before and after precystectomy radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1987;10(2):149-55.
1987: Fosså S D; Borge L; Aass N; Johannessen N B; Stenwig A E; Kaalhus O
The treatment of advanced metastatic seminoma: experience in 55 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1071-7.
1987: Paus E; Fosså S D; Risberg T; Nustad K
The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma.
British journal of urology 1987;59(6):572-7.
1987: Sager E M; Talle K; Fosså S D; Ous S; Stenwig A E
Contrast-enhanced computed tomography to show perivesical extension in bladder carcinoma.
Acta radiologica (Stockholm, Sweden : 1987) 1987;28(3):307-11.
1987: Lien H H; Lindsköld L; Stenwig A E; Ous S; Fosså S D
Shape of retroperitoneal lymph nodes at computed tomography does not correlate to metastatic disease in early stage non-seminomatous testicular tumors.
Acta radiologica (Stockholm, Sweden : 1987) 1987;28(3):271-3.
1987: Flokkmann A; Fosså S D; Karlsen K O
[Radiotherapy and chemotherapy in anal carcinoma]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1987;107(1):50-2, 61.
1987: Telhaug R; Fosså S D; Ous S
Definitive radiotherapy of prostatic cancer: the Norwegian Radium Hospital's experience (1976-1982).
The Prostate 1987;11(1):77-86.
1987: Fosså S D; Dingsør E; Johannessen N B; Kvarstein B; Stenwig A E; Urnes T; Waehre H; Ogreid P
Pre-cystectomy chemotherapy in patients with muscle infiltrating bladder carcinoma. A multicentre feasibility study.
Scandinavian journal of urology and nephrology 1987;21(1):39-42.
1987: Wanderås E H; Fosså S D; Tveit K M; Flokkmann A
Sequential 5-fluorouracil and methotrexate. Negative experience in metastatic colorectal cancer.
Acta oncologica (Stockholm, Sweden) 1987;26(4):289-93.
1987: Fosså S D; Hall K S; Johannessen N B; Urnes T; Kaalhus O
Cancer of the penis. Experience at the Norwegian Radium Hospital 1974-1985.
European urology 1987;13(6):372-7.
1987: Fosså S D
Palliative pelvic radiotherapy in patients with hormone-resistant prostatic cancer.
Progress in clinical and biological research 1987;243B():479-85.
1987: Fosså S D; Urnes T; Kaalhus O
Weekly low-dose adriamycin in hormone-resistant metastatic cancer of the prostate.
Scandinavian journal of urology and nephrology 1987;21(1):13-6.
1986: Fosså S D; Thorud E; Pettersen E O; Shoaib M C; Scott-Knudsen O; Ous S
DNA flow cytometry in human bladder carcinoma.
Pathology, research and practice 1986;181(3):291-5.
1986: Fosså S D; Thorud E; Shoaib M C; Pettersen E O
DNA flow cytometry of cells obtained from old paraffin-embedded specimens. A comparison with results of scanning absorption cytometry (a methodological study).
Pathology, research and practice 1986;181(2):200-5.
1986: Thorud E; Fosså S D; Vaage S; Kaalhus O; Knudsen O S; Børmer O; Shoaib M C
Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics.
Cancer 1986;57(4):808-11.
1985: Fosså S D; Ous S; Abyholm T; Norman N; Loeb M
Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production.
British journal of urology 1985;57(2):210-4.
1985: Fosså S D; Urnes T; Ous S
Short-term and long-term effect of prophylactic treatment of superficial bladder cancer with intravesical adriamycin.
European urology 1985;11(6):382-5.
1984: Fosså S D; Thorud E; Shoaib M C; Pettersen E O; Høie J; Knudsen O S
DNA flow cytometry in primary breast carcinoma.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology 1984;92(6):475-80.
1983: Fosså S D; Thorud E; Vaage S; Shoaib M C
DNA cytometry of primary breast cancer. Comparison of microspectrophotometry and flow cytometry, and different preparation methods for flow cytometric measurements.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology 1983;91(4):235-43.
1983: Fosså S D; Heilo A; Lindegaard M; Skinningrud A; Ous S
Clinical significance of routine follow-up examinations in patients with metastatic cancer of the prostate under hormone treatment.
European urology 1983;9(5):262-6.
1982: Fosså S D; Marton P F; Knudsen O S; Kaalhus O; Børmer O; Vaage S
Nuclear feulgen DNA content and nuclear size in human breast carcinoma.
Human pathology 1982;13(7):626-30.

Sign-in to see more